Lightning Health Market Access Review 2021
A return to the ‘new normal’ – innovations and policies that shaped this year
For your copy of the review, complete the form below.
2021 has been a year of important developments in the field of pharmaceutical market access, with lasting implications for the development and launch of new medicines across the globe.
In this review, we report on the key developments across major global markets that have taken place over the past year, which will shape the access landscape for new medicines.
Eleanor Butler, Consultant at Lightning Health has led the development of this year’s review.